Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair
NCT ID: NCT02168439
Last Updated: 2024-11-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2014-06-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
NCT05057689
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED
NCT05934669
Intranasal Dexmedetomidine Dose-finding Study
NCT03957304
Anxiolysis for Laceration Repair in Children
NCT05383495
Dexmedetomidine Versus Propofol in Vitreoretinal Surgery
NCT01001429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexmedetomidine
Intranasal Dexmedetomidine 2 micrograms/kilogram once
Dexmedetomidine
Midazolam
Intranasal Midazolam 0.4 milligram/kilogram
Midazolam
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
Midazolam
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Laceration \<5 cm in total length
* Require simple suture laceration repair
Exclusion Criteria
* Lacerations requiring complex (multilayer) repair or total laceration length\>5cm
1 Year
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh Clinical and Translational Science Institute (CTSI)
UNKNOWN
National Center for Advancing Translational Sciences (NCATS)
NIH
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Desiree Neville, MD
M.D., Pediatric Emergency Medicine Fellow Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Desiree Neville, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO13120431
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.